We appreciate all people who have supported us in various fields over the past year since our incorporation on February 8, 2021. We kindly inform you that we have prepared an annual report summarizing our activities in 2021.
We will continue working with the aim of improving the early detection and diagnosis rates of HAE to help patients who are suffering from undiagnosed hereditary angioedema.